Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland (original) (raw)
Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo MS, Banerjee SK . (2003). WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia5: 63–73. ArticleCAS Google Scholar
Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene19: 968–988. ArticleCAS Google Scholar
Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M et al. (2002). The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res62: 4736–4745. CASPubMed Google Scholar
Hewitt RE, Brown KE, Corcoran M, Stetler-Stevenson WG . (2000). Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line. J Pathol192: 455–459. ArticleCAS Google Scholar
Ito M, Jiang C, Krumm K, Zhang X, Pecha J, Zhao J et al. (2003). TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Res63: 8763–8767. CASPubMed Google Scholar
Jiang C, Ito M, Piening V, Bruck K, Roeder RG, Xiao H . (2004). TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription. J Biol Chem279: 27781–27789. ArticleCAS Google Scholar
King FW, Shtivelman E . (2004). Inhibition of nuclear import by the proapoptotic protein CC3. Mol Cell Biol24: 7091–7101. ArticleCAS Google Scholar
Lee H, Park DS, Razani B, Russell RG, Pestell RG, Lisanti MP . (2002). Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (−/−) null mice show mammary epithelial cell hyperplasia. Am J Pathol161: 1357–1369. ArticleCAS Google Scholar
Lee LW, Zhang DH, Lee KT, Koay ES, Hewitt RE . (2004). CC3/TIP30 expression was strongly associated with HER-2/NEU status in breast cancer. Ann Acad Med Singap33: S30–S32. CASPubMed Google Scholar
Ma ZQ, Chua SS, DeMayo FJ, Tsai SY . (1999). Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B. Oncogene18: 4564–4576. ArticleCAS Google Scholar
Medina D . (2002). Biological and molecular characteristics of the premalignant mouse mammary gland. Biochim Biophys Acta1603: 1–9. CASPubMed Google Scholar
Medina D, Kittrell F . (2000). Establishment of mouse mammary cell lines. In: Ip MM, Ash BB (eds). Methods in Mammary Gland Biology and Breast Cancer. Kluwer Academic/Plenum Publishers: New York, pp 137–145. Chapter Google Scholar
Medina D, Kittrell FS . (1993). Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo. Carcinogenesis14: 25–28. ArticleCAS Google Scholar
Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P . (2001). The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res61: 1250–1254. CASPubMed Google Scholar
Oh A, List HJ, Reiter R, Mani A, Zhang Y, Gehan E et al. (2004). The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res64: 8299–8308. ArticleCAS Google Scholar
Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M et al. (1997). Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol139: 1025–1032. ArticleCAS Google Scholar
Saxena N, Banerjee S, Sengupta K, Zoubine MN, Banerjee SK . (2001). Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines. Mol Cell Biochem228: 99–104. ArticleCAS Google Scholar
Shillingford JM, Miyoshi K, Flagella M, Shull GE, Hennighausen L . (2002). Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: characterization, localization, and involvement in ductal development and morphogenesis. Mol Endocrinol16: 1309–1321. ArticleCAS Google Scholar
Shtivelman E . (1997). A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene14: 2167–2173. ArticleCAS Google Scholar
Ullrich RL, Bowles ND, Satterfield LC, Davis CM . (1996). Strain-dependent susceptibility to radiation-induced mammary cancer is a result of differences in epithelial cell sensitivity to transformation. Radiat Res146: 353–355. ArticleCAS Google Scholar
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG et al. (2002). The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature419: 624–629. ArticleCAS Google Scholar
Wang J, Xie LY, Allan S, Beach D, Hannon GJ . (1998). Myc activates telomerase. Genes Dev12: 1769–1774. ArticleCAS Google Scholar
Xiao H, Tao Y, Greenblatt J, Roeder RG . (1998). A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci USA95: 2146–2151. ArticleCAS Google Scholar
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T et al. (1999). Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet22: 37–43. ArticleCAS Google Scholar
Zhang S, Li X, Burghardt R, Smith R, Safe SH . (2005). Role of estrogen receptor (ER) alpha in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells. J Mol Endocrinol35: 433–447. ArticleCAS Google Scholar
Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D . (2004). 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation. J Biol Chem279: 34353–34360. ArticleCAS Google Scholar
Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F et al. (2006). TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Hum Pathol38: 293–298. Article Google Scholar